UnitedHealth Group Stock Trades Below Fair Value Amid Regulatory Risks

UnitedHealth Group (UNH) stock has delivered impressive returns over the past year, but its valuation checks currently lean cheap. The company's stock price has returned 30.3% over the last 12 months, which means recent pullbacks sit against a solid one-year gain that investors are weighing against current risks.

Shareholder lawsuits, regulatory attention on taxes and Medicare billing, and political pressure on vertical integration may cap how much investors are prepared to pay for future cash flows. Despite these challenges, the core health insurance and services businesses can still support earnings power in the long run.

The issue now is whether the current share price already reflects the legal, regulatory, and political risks that surround UnitedHealth Group, or if the valuation gap on those checks still leaves room for upside. On traditional metrics, UnitedHealth Group screens as undervalued in 6 of 6 areas, which points to a stock that its current market price does not fully reflect.